Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Biomarkers In Cerebrospinal Fluid

Biomarkers in cerebrospinal fluid can identify patients with Alzheimer’s disease

Analysis of specific biomarkers in a cerebrospinal fluid sample can differentiate patients with Alzheimer’s disease from those with other types of dementia. The method, which is being studied by researchers at Sahlgrenska Academy, may eventually permit earlier detection of Alzheimer’s disease.

Due to the similarity of the symptoms, differentiating patients with Alzheimer’s from those… Biomarkers in cerebrospinal fluid can identify patients with Alzheimer’s disease   



Alzheimer’s Disease

emission computed tomography1 - sleep1 - fronto temporal lobar degeneration1 - verbal fluency1 - tfp5 treatment1 - alzheimer's dementia2 - physical activity2 - amyloid hypothesis1 - motor development1 - stress2 - treatment of alzheimer's disease1 - imbeciles1 - early alzheimer's damage1 - alzheimer’s and dementia1 - als1 - general activity1 - dimebon1 - cardiovascular disease1 - age-related cognitive disorders1 - igf-11 - behavioural deterioration1 - pomegranate1 - wernicke-korsakoff syndrome15 - dementia and down’s syndrome1 - mini-strokes2 - impaired-memory disorder1 - early stage alzheimers1 - hippocampus6 - aids related dementia1 - dementia screening1 -